Cell cycle regulation in diabetic nephropathy

Kidney International, Supplement

Volumn 58, Issue 77, 2000, Pages

  Wolf, G ^a  

^a Division of Nephrology and Osteology   (Germany)

Author keywords

Cell cycle regulation; Diabetic nephropathy; Fibrosis; Hypertrophy; P27kip1; Progression of renal disease

Indexed keywords

ANGIOTENSIN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; SERINE; TRANSFORMING GROWTH FACTOR BETA; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CDKN1A PROTEIN, RAT; CDKN1B PROTEIN, MOUSE; CDKN1B PROTEIN, RAT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; FIBROBLAST; FIBROGENESIS; KIDNEY DEVELOPMENT; KIDNEY HYPERTROPHY; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; GROWTH, DEVELOPMENT AND AGING; HUMAN; KIDNEY; MESANGIUM; MOUSE; PATHOLOGY; PHYSIOLOGY; RAT;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DIABETIC NEPHROPATHIES; GLOMERULAR MESANGIUM; HUMANS; KIDNEY; MICE; MICROTUBULE-ASSOCIATED PROTEINS; RATS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033864452     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07710.x     Document Type: Review

References (88)

1. Molecular mechanisms of diabetic renal hypertrophy
2. The renal tubulointerstitium in diabetes mellitus
3. The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury
4. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney
5. Hyperglycemia-pathophysiological aspects at the cellular level
6. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy
7. Efficient morphometric analysis of glomerular mesangium in insulin-dependent diabetic patients with early nephropathy
8. Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: Causes, consequences, and prevention
9. On the prognosis of IDDM patients with larger kidneys
10. Growth factors and diabetic nephropathy: An overview
11. Diabetic kidney disease: The role of growth factors
12. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β
13. Molecular mechanisms of renal hypertrophy: Role of p27(Kip1)
14. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy
15. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
16. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas
17. Mesangial cell signaling cascades in response to mechanical strain and glucose
18. Mechanical strain and high glucose induced alterations in mesangial cell collagen metabolism: Role of TGF-β
19. The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms
20. Understanding the nature of renal disease progression
21. Molecular interactions between albumin and proximal tubular cells
22. Vasoactive factors and tubulointerstitial injury
23. Role of angiotensin II in diabetic nephropathy
24. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth
25. The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture
26. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGF-β
27. Cellular events in the evolution of experimental diabetic nephropathy
28. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β
29. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator
30. ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop
31. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells
32. Molecular mechanisms of angiotensin II in the kidney: Emerging role in the progression of renal disease beyond haemodynamics
33. mRNA expression of growth factors in glomeruli from diabetic rats
34. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes
35. In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rats
36. Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis
37. A role for leptin in glomerulosclerosis?
38. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
39. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes
40. The role of diabetes mellitus in the aetiology of renal cell cancer
41. Decreased glomerular proteinase activity in the streptozotocin diabetic rat
42. Decreased proteinase activity in isolated glomeruli of streptozotocin diabetic rats
43. Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic lysosomal enzymes
44. Glomerular and tubular membrane antigens reflecting cellular adaptation in human renal failure
45. Angiotensinase: A gene expression and enzyme activity in isolated glomeruli of diabetic rats
46. 1 cells
47. Cellular mechanisms of tubule hypertrophy and hyperplasia
48. Cell cycle regulatory proteins in renal disease
49. Cyclins and the cyclin-kinase system - Their potential roles in nephrology
50. Renal epithelial cell hyperplasia and hypertrophy
51. Cell-cycle control in renal disease
52. A cell cycle-dependent mechanism of renal tubule epithelial cell hypertrophy
53. Regulation of mesangial cell proliferation
54. Cell cycle regulatory proteins in glomerular disease
55. Expression of growth-related protooncogenes during diabetic renal hypertrophy
56. High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures
57. High glucose stimulates expression of p27(Kip1) in cultured mouse mesangial cells: Relationship to hypertrophy
58. Glomerular expression of p27(Kip1) in diabetic db/db mouse: Role of hyperglycemia
59. 1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27(Kip1)
60. Angiotensin II-mediated expression of p27(Kip1) and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals
61. Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli
62. 1
63. Activation of mitogen-activated protein kinase cascade in diabetic glomeruli and mesangial cells cultured under high glucose conditions
64. The cyclin kinase inhibitor p21(WAF1.Cip1) is increased in experimental diabetic nephropathy: Potential role in glomerular hypertrophy
65. The cyclin kinase inhibitor p21(WAF1/CIP1) is required for glomerular hypertrophy in experimental diabetic nephropathy
66. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition
67. Effects of angiotensin-converting enzyme inhibitors in experimental diabetes
68. ACE inhibitor treatment reduces glomerular p16(INK4 and) p27(Kip1) expression in diabetic BBdp rats
69. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia
70. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule
71. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule
72. + antiport activity
73. Involvement of pRB family in TGFβ-dependent epithelial cell hypertrophy
74. TGF-β-mediated hypertrophy in rat renal epithelial cells involves inhibiting pRB phosphorylation by preventing activation of cdk2/cyclin E kinase
75. TGF beta inhibition of cdk4 synthesis is linked to cell cycle arrest
76. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
77. 3H-thymidine uptake in diabetic and uninephrectomized rats
78. Autoradiographic studies on the proliferation of glomerular and tubular cells of the rat kidney in early diabetes
79. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes
80. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys
81. Glucose toxicity for human endothelial cells in culture: Delayed replication, disturbed cell cycle, and accelerated death
82. The cyclin-kinase inhibitor p27(Kip1) safeguards against inflammatory injury
83. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(KIP1)
84. Cleavage of p21 (Cip1/Waf1) and p27(Kip1) mediates apoptosis in endothelial cells through activation of CDK2: Role of a caspase cascade
85. A half-century experience in diabetes mellitus
86. Nephropathy in patients with type 2 diabetes mellitus
87. Size does matter: Will knockout of p21(WAF1/CIP1) save the kidney by limiting compensatory renal growth?